Sanofi Filler
Hygienic Synvisc G-F 20 3x2ml
16824
Synvisc It is composed of Hylan G-F 20 is a sterile viscoelastic liquid, apoish, containing Hylan.Hylan G-F 20 temporarily reconstitutes the viscoelasticity of the synovial liquid, brings clinical benefits to patients in all stages of arthrosis of the joints, is more effective in patients who actively and regularly use the articulation affected by the pathology, and reaches its therapeutic effect through theViscosupplementation, a process through which the physiological state and the retiological characteristics of the synovial fluid of the arthritic articulation are reintegrated.Hylan are derived from hyaluronate (sodium salt of hyaluronic acid) and are made up of unconventional unconventive units of n-acetylglucosamine and sodium glucuronate.Hylan A has an average molecular weight of about 6,000,000 Dalton and Hylan B is an hydrogel.Hylan G-F 20 contains Hylan A and B (8.0 mg ± 2.0 mg per ml) in sodium chloride buffered physiological solution (pH 7.2 ± 0.3).
Viscosupplement with Hylan G-F 20 is indicated to relieve pain and functional limitations, allowing a more extensive movement of the joint.In vitro studies have shown that Hylan G-F 20 protects cartilage cells from damage due to the action of physical and chemical agents.
Synvisc-One is indicated only for the intra-articular use by a doctor in the treatment of pain associated with knee arthrosis.
Dosage
The dosage scheme of Hylan G-F 20 depends on the joint to be treated.
Knee arthrosis: recommended treatment regime for Synvisc is three injections of 2 ml in the knee, after a week from each other.To achieve the optimal effect, it is essential to practice all three injections.The recommended maximum dosage is six injections over six months, with a pause of at least four weeks between the treatment regimes.
Artosis of the hip, ankle and shoulder: recommended initial treatment regime is a single injection of 2 ml.However, it is recommended to practice a second injection of 2 ml if an adequate symptomatic benefit of pain is not obtained.Clinical data have shown that patients benefit from this second injection if practiced after one-three months from the first
Generally a maximum duration of the effect has been found for patients who respond well to treatment up to 26 weeks, even if shorter or longer periods have been observed.Data extrapolated from perspective clinical studies conducted on patients with knee arthrosis have shown treatment benefits of up to 52 weeks, after a single treatment cycle of three synvisc injections.
Ingredients/INCI
Each ml contains: Hylan 8.0 mg, sodium chloride 8.5 mg, disodium phosphate hydrogen 0.16 mg, dioxide sodium phosphate hydrated 0.04 mg, water for preparations injectable enough.
Format
Package with 3 glass syringes of 2.25 ml caduna pre -rated with 2 ml caduna.of Hylan G-F 200. Store at a temperature between +2 ° C and +30 ° C.Do not freeze.
Viscosupplement with Hylan G-F 20 is indicated to relieve pain and functional limitations, allowing a more extensive movement of the joint.In vitro studies have shown that Hylan G-F 20 protects cartilage cells from damage due to the action of physical and chemical agents.
Synvisc-One is indicated only for the intra-articular use by a doctor in the treatment of pain associated with knee arthrosis.
Dosage
The dosage scheme of Hylan G-F 20 depends on the joint to be treated.
Knee arthrosis: recommended treatment regime for Synvisc is three injections of 2 ml in the knee, after a week from each other.To achieve the optimal effect, it is essential to practice all three injections.The recommended maximum dosage is six injections over six months, with a pause of at least four weeks between the treatment regimes.
Artosis of the hip, ankle and shoulder: recommended initial treatment regime is a single injection of 2 ml.However, it is recommended to practice a second injection of 2 ml if an adequate symptomatic benefit of pain is not obtained.Clinical data have shown that patients benefit from this second injection if practiced after one-three months from the first
Generally a maximum duration of the effect has been found for patients who respond well to treatment up to 26 weeks, even if shorter or longer periods have been observed.Data extrapolated from perspective clinical studies conducted on patients with knee arthrosis have shown treatment benefits of up to 52 weeks, after a single treatment cycle of three synvisc injections.
Ingredients/INCI
Each ml contains: Hylan 8.0 mg, sodium chloride 8.5 mg, disodium phosphate hydrogen 0.16 mg, dioxide sodium phosphate hydrated 0.04 mg, water for preparations injectable enough.
Format
Package with 3 glass syringes of 2.25 ml caduna pre -rated with 2 ml caduna.of Hylan G-F 200. Store at a temperature between +2 ° C and +30 ° C.Do not freeze.
Hygienic Synvisc G-F 20 3x2ml
16824
Estimated delivery between September 20 and September 22.
Synvisc It is composed of Hylan G-F 20 is a sterile viscoelastic liquid, apoish, containing Hylan.Hylan G-F 20 temporarily reconstitutes the viscoelasticity of the synovial liquid, brings clinical benefits to patients in all stages of arthrosis of the joints, is more effective in patients who actively and regularly use the articulation affected by the pathology, and reaches its therapeutic effect through theViscosupplementation, a process through which the physiological state and the retiological characteristics of the synovial fluid of the arthritic articulation are reintegrated.Hylan are derived from hyaluronate (sodium salt of hyaluronic acid) and are made up of unconventional unconventive units of n-acetylglucosamine and sodium glucuronate.Hylan A has an average molecular weight of about 6,000,000 Dalton and Hylan B is an hydrogel.Hylan G-F 20 contains Hylan A and B (8.0 mg ± 2.0 mg per ml) in sodium chloride buffered physiological solution (pH 7.2 ± 0.3).
Viscosupplement with Hylan G-F 20 is indicated to relieve pain and functional limitations, allowing a more extensive movement of the joint.In vitro studies have shown that Hylan G-F 20 protects cartilage cells from damage due to the action of physical and chemical agents.
Synvisc-One is indicated only for the intra-articular use by a doctor in the treatment of pain associated with knee arthrosis.
Dosage
The dosage scheme of Hylan G-F 20 depends on the joint to be treated.
Knee arthrosis: recommended treatment regime for Synvisc is three injections of 2 ml in the knee, after a week from each other.To achieve the optimal effect, it is essential to practice all three injections.The recommended maximum dosage is six injections over six months, with a pause of at least four weeks between the treatment regimes.
Artosis of the hip, ankle and shoulder: recommended initial treatment regime is a single injection of 2 ml.However, it is recommended to practice a second injection of 2 ml if an adequate symptomatic benefit of pain is not obtained.Clinical data have shown that patients benefit from this second injection if practiced after one-three months from the first
Generally a maximum duration of the effect has been found for patients who respond well to treatment up to 26 weeks, even if shorter or longer periods have been observed.Data extrapolated from perspective clinical studies conducted on patients with knee arthrosis have shown treatment benefits of up to 52 weeks, after a single treatment cycle of three synvisc injections.
Ingredients/INCI
Each ml contains: Hylan 8.0 mg, sodium chloride 8.5 mg, disodium phosphate hydrogen 0.16 mg, dioxide sodium phosphate hydrated 0.04 mg, water for preparations injectable enough.
Format
Package with 3 glass syringes of 2.25 ml caduna pre -rated with 2 ml caduna.of Hylan G-F 200. Store at a temperature between +2 ° C and +30 ° C.Do not freeze.
Viscosupplement with Hylan G-F 20 is indicated to relieve pain and functional limitations, allowing a more extensive movement of the joint.In vitro studies have shown that Hylan G-F 20 protects cartilage cells from damage due to the action of physical and chemical agents.
Synvisc-One is indicated only for the intra-articular use by a doctor in the treatment of pain associated with knee arthrosis.
Dosage
The dosage scheme of Hylan G-F 20 depends on the joint to be treated.
Knee arthrosis: recommended treatment regime for Synvisc is three injections of 2 ml in the knee, after a week from each other.To achieve the optimal effect, it is essential to practice all three injections.The recommended maximum dosage is six injections over six months, with a pause of at least four weeks between the treatment regimes.
Artosis of the hip, ankle and shoulder: recommended initial treatment regime is a single injection of 2 ml.However, it is recommended to practice a second injection of 2 ml if an adequate symptomatic benefit of pain is not obtained.Clinical data have shown that patients benefit from this second injection if practiced after one-three months from the first
Generally a maximum duration of the effect has been found for patients who respond well to treatment up to 26 weeks, even if shorter or longer periods have been observed.Data extrapolated from perspective clinical studies conducted on patients with knee arthrosis have shown treatment benefits of up to 52 weeks, after a single treatment cycle of three synvisc injections.
Ingredients/INCI
Each ml contains: Hylan 8.0 mg, sodium chloride 8.5 mg, disodium phosphate hydrogen 0.16 mg, dioxide sodium phosphate hydrated 0.04 mg, water for preparations injectable enough.
Format
Package with 3 glass syringes of 2.25 ml caduna pre -rated with 2 ml caduna.of Hylan G-F 200. Store at a temperature between +2 ° C and +30 ° C.Do not freeze.
our satisfaction is our priority. If you have changed your mind about your purchase, you have 14 days from the delivery date to inform us and return the product.
Conditions: The product must be perfectly intact, unused, and returned in its sealed original packaging. For hygiene reasons, we cannot accept products that have been opened.
Procedure: To initiate a return, contact our Customer Service at customercare@dermadea.com.
Shipping Costs: The shipping costs for returning the product are your responsibility.
For all the details, please consult our General Terms and Conditions of Sale.
We are committed to providing you with perfect products. If you receive a damaged, defective, or incorrect item, you are protected by the Legal Guarantee of Conformity.
What to Do: Immediately contact our Customer Service at customercare@dermadea.com, describing the issue and attaching a photo of the product if possible.
Solution: We will arrange for a product replacement or a full refund, depending on the situation.
Shipping Costs: In the event of a defective or non-compliant product, the shipping costs for the return are entirely at our expense.
For all the details, please consult our General Terms and Conditions of Sale.
16824